Archive for the ‘small-clinical’ tag
ASCO GI: Agent Targets IGF Receptor in Pancreatic Cancer (CME/CE) (source: medpagetoday.com) no comments
ORLANDO (MedPage Today) — A majority of patients with advanced pancreatic cancer had objective responses or stable disease when treated with an inhibitor of insulin-like growth factor receptor, data from a small clinical trial showed. (source: medpagetoday.com) - RSS widgets and RSS feeds on Feedzilla.com
Read the original:
ASCO GI: Agent Targets IGF Receptor in Pancreatic Cancer (CME/CE) (source: medpagetoday.com)
ASCO GI: Targeted Regimen Active in Esophageal Cancer (source: medpagetoday.com) no comments
Half of patients with metastatic esophageal cancer responded to a regimen of conventional chemotherapy and erlotinib (Tarceva), investigators in a small clinical trial reported here. (source: medpagetoday.com) - RSS feeds and Feed widget on Feedzilla.com
Go here to see the original:
ASCO GI: Targeted Regimen Active in Esophageal Cancer (source: medpagetoday.com)
ASCO GI: Targeted Agent Slows Neuroendocrine Tumors (source: medpagetoday.com) no comments
ORLANDO (MedPage Today) — Patients with progressive pancreatic neuroendocrine tumors lived twice as long without progression when treated with sunitinib (Sutent) compared with placebo, data from a French clinical trial showed. (source: medpagetoday.com) - RSS and News widget on Feedzilla.com
Read the original here:
ASCO GI: Targeted Agent Slows Neuroendocrine Tumors (source: medpagetoday.com)